|
RESERVED AREA
| LANGUAGE
Lung Cancer Study Group
GECP
WHO WE ARE
STATUTS
SOCIAL BODIES
SCIENTIFIC COMMISSION
ACTION PLAN
CONTACTS
ASSOCIATED CENTERS
NEW PARTNERS
CLINICAL TRIALS
WHAT IS A CLINICAL TRIAL?
GEP´s CLINICAL TRIALS
ESTUDOS OBSERVACIONAIS EM RECRUTAMENTO NACIONAL
Em atualização
Em atualização
use
ONGOING TRIALS
ENSAIOS RECRUTAMENTO NACIONAL INVESTIGADOR
PUBLICATIONS
25 Anos GECP
GECP JOURNAL
Acesso à Revista
JOURNAL ACCESS
Critérios de publicação
campaign
interviews
books
EVENTS
GECP
PREVIOUS CONGRESSES
MEETINGS
SPRING
AUTUMN
SCIENTIFIC SPONSORSHIP
patrocinado
GRANTS AND AWARDS
BOLSAS GECP
GECP AWARD
PATIENTS AND CAREGIVERS
LUNG CANCER
CANCER AND COVID-19
PUBLICATIONS
FREQUENTLY ASKED QUESTIONS
TOBACCO
ASSOCIATIONS
PATIENT'S DUTIES AND RIGHTS
LEGISLATION
INFORMATIONS
INTERNATIONAL
WHO - tobacco
90% of lung cancers can be avoided by eliminating tobacco use, new WHO report reveals
Tobacco use and COVID-19
WHO statement: Tobacco use and COVID-19
WHO - Report
European Tobacco Use – trends report 2019
GECP
WHO WE ARE
STATUTS
SOCIAL BODIES
SCIENTIFIC COMMISSION
ACTION PLAN
CONTACTS
ASSOCIATED CENTERS
NEW PARTNERS
CLINICAL TRIALS
WHAT IS A CLINICAL TRIAL?
GEP´s CLINICAL TRIALS
ESTUDOS OBSERVACIONAIS EM RECRUTAMENTO NACIONAL
Em atualização
Em atualização
use
ONGOING TRIALS
ENSAIOS RECRUTAMENTO NACIONAL INVESTIGADOR
PUBLICATIONS
25 Anos GECP
GECP JOURNAL
Acesso à Revista
JOURNAL ACCESS
Critérios de publicação
campaign
interviews
books
EVENTS
GECP
PREVIOUS CONGRESSES
MEETINGS
SCIENTIFIC SPONSORSHIP
patrocinado
GRANTS AND AWARDS
BOLSAS GECP
GECP AWARD
PATIENTS AND CAREGIVERS
LUNG CANCER
CANCER AND COVID-19
PUBLICATIONS
FREQUENTLY ASKED QUESTIONS
TOBACCO
ASSOCIATIONS
PATIENT'S DUTIES AND RIGHTS
LEGISLATION
The GECP website uses cookies to allow a better user experience. By browsing you are consenting to its use.
Close
Privacy policy
